Adam Kimmerling, PA-C

Adam Kimmerling practices at AdventHealth Carrollwood in Tampa, Florida, part of AdventHealth.

Adam Kimmerling's NPI, 1902283856, was assigned on April 29, 2015. Adam Kimmerling holds Florida license PA9108682.

Adam Kimmerling's primary practice is AdventHealth Carrollwood, at 7171 N Dale Mabry Hwy, Tampa, FL 33614 in Hillsborough County. The practice phone is (813) 615-7219.

Adam Kimmerling's primary practice is AdventHealth Carrollwood in Tampa, Florida, part of AdventHealth. The medical group on file is Emergency Medicine Physicians. Dmand AI also links Adam Kimmerling to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Adam Kimmerling practices, 3 sites in all. Vendor and product names are available with a free account.

Medical is Adam Kimmerling's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Adam Kimmerling is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Adam Kimmerling is licensed in Florida.

Dmand AI lists asthma and chronic obstructive pulmonary disease (COPD) among the conditions Adam Kimmerling treats.

CMS data shows 270 Medicare services from Adam Kimmerling across 4 procedure codes in 2024, for 211 Medicare patients. Medicare paid $20,767 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 211 Medicare patients who saw Adam Kimmerling in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Adam Kimmerling's median patient age at 52, with 59% women.

In 2024, Adam Kimmerling wrote 354 Medicare Part D claims for 261 patients. 96% of them were for generic drugs. CMS names the drug for 236 of them, across 10 drugs with 11 or more claims each, at $1,821 in total drug cost.

CMS Open Payments shows 3 general payments to Adam Kimmerling from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $151.